Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
July 31, 2008

Buck Institute Is Invitrogen’s Latest Source for Engineered Stem Cell Lines

  • Invitrogen licensed an engineered stem cell line from the Buck Institute for Age Research. Called BG01 Olig2-GFP, the stem cell line is engineered to track the Olig2 gene. This gene controls a protein that maintains a neural stem cell’s ability to replicate early in brain development and then directs it to form a particular type of neural cell.

    “This line of stem cells adds to Invitrogen’s expanding portfolio of engineered stem cells,” notes Joydeep Goswami, Invitrogen vp of primary and stem cell systems. In May, the company obtained a license for human embryonic stem cell patents from WARF, the Wisconsin Alumni Research Foundation.